Birth of a Blockbuster

From Misalignment to Market Leader: How Open Water Helped Set the Stage for a $13.3B Blockbuster

$1B to $13.3B

Unlocking growth through alignment

One Team, One Goal

Turning misalignment into success

Mindset Shift

Sparked breakthrough growth

Alighment, Cohesion & Clarity
Growth & Performance

The same team that launched the brand was the one that turned it around. Once trust was established, we could take bold steps with confidence. The rest is history.

Tolga Tangular, Former President of Rare Diseases, Pfizer, USA

When Pfizer partnered with another global pharmaceutical company to bring a next-generation anticoagulant to market, the opportunity was enormous. The drug had the potential to change the lives of heart and stroke patients worldwide. Yet, despite its clinical promise, it was failing to gain traction in the market.

The challenge wasn’t the science – it was alignment.

The Challenge: A Partnership Without a Shared Path Forward

Pharmaceutical drug development is a high-stakes game. Costs run into the billions, timelines span decades, and even the most promising therapies face steep commercial hurdles. Pfizer had entered into an alliance to share both the financial burden and the rewards of this new product. But while the partnership made sense on paper, it was faltering in execution.

The disconnect was clear:


• Competing Commercial Approaches – The two companies had different strategies for launching and positioning the drug.
• Internal Misalignment – Even within Pfizer, teams were not fully invested in the product.
• A Lack of Trust – Decision-making was fragmented, slowing progress and undermining momentum.

As Tolga Tangular, Former President of Rare Diseases at Pfizer, put it:


"Everybody expected this product to succeed, but there was no shared clarity on how to get there – not just between the two companies, but even within our own teams."

The Solution: Open Water’s Culture-First Approach

Pfizer engaged Open Water to align leadership, build trust, and instil a shared sense of ownership. Our role was to lay the foundation for long-term success by shifting mindsets, fostering collaboration, and ensuring the alliance could operate as a high-performing team:


1. Creating Internal Alignment at Pfizer

Before the alliance could work together effectively, Pfizer’s own teams needed to take full ownership of the drug. We helped shift internal perceptions, ensuring they saw the product as integral to their portfolio rather than just a co-developed asset.

2. Establishing Trust Between Organisations

Through confidential interviews and leadership coaching, we surfaced unspoken tensions and roadblocks. By addressing these early, we helped leaders move from a transactional partnership to a collaborative alliance.

3. Designing a Clear, Collaborative Roadmap

Open Water facilitated intensive workshops that enabled the alliance to develop a shared commercial strategy. A phased market approach was introduced – targeting cardiologists first before expanding to primary care.

4. Instilling a Winning Mindset

One of the biggest barriers was belief. Neither company truly saw the drug as a category leader. By shifting their internal messaging and creating a culture of shared ambition, we helped the alliance move from skepticism to confidence.

Setting the Stage for Long-Term Growth

The results were transformative:


• Cultural Shift – The alliance moved from a blame-based culture to one of shared ownership and trust.
• Clear Strategy – A targeted, phased approach streamlined decision-making and execution.
• Mindset Transformation – Leaders and teams believed in their product – and that belief drove market success.
• A Strong Foundation for Growth – The alliance team became aligned and equipped to execute with clarity.

At the time of Open Water’s engagement, the drug was generating $1 billion in annual revenue. By helping the alliance reset its approach, we enabled the conditions for future success. Over the following decade, the product continued to gain momentum, becoming one of the world’s top-selling drugs, reaching $13.3 billion in 2024.


A Lasting Impact

"The same team that launched the brand was the one that turned it around. Once trust was established, we could take bold steps with confidence. The rest is history."
Tolga Tangular, Former President of Rare Diseases, Pfizer, USA


The work done at the time helped remove the internal barriers holding the product back, allowing the alliance to build on this momentum in the years that followed. Today, the brand continues to evolve and expand – something that wouldn’t have been possible without the strong foundation established during Open Water’s intervention.

Ready to launch your blockbuster drug on the market or turn sales around? Let’s connect.
< Drag >

Birth of a Blockbuster

From Misalignment to Market Leader: How Open Water Helped Set the Stage for a $13.3B Blockbuster

$1B to $13.3B

Unlocking growth through alignment

One Team, One Goal

Turning misalignment into success

Mindset Shift

Sparked breakthrough growth

Growing Pains

A global CRO equips its leaders and managers to navigate change with empathy, passion and purpose

Post Merger

Post multiple mergers: building trust and cohesion in a global CRO

100%

of managers now equipped to lead with empathy and purpose

Transformation

Empowering leaders to inspire change and drive transformation

The Compliance Shift

How a trusted advisor approach revolutionised compliance behaviour

19%

increase in accountability and client trust

15%

increase in self-management skills and growth mindset behaviour

Customer Centricity

Improved connection and rapport with healthcare professionals (HCPs)

Sales Remedy

Open Water’s Connected Partner Program transformed a sales force into trusted advisors, driving a 20% sales uplift for a new psychiatric drug and revitalising stagnant product sales through customer-centric engagement.

20%

sales uplift for the newly launched drug across EMEA

16%

increase in sales of other products sold by the same sales force

80%

increase in time spent with healthcare professionals (HCPs)

Prepare for Sale

A new narrative focused on connection to purpose, energises, empowers and refocuses the senior team of a lacklustre immuno-inflammatory business

$6.7B

add to the pharmaceutical’s most undervalued asset

2,500

global team members united with a bold new narrative

52%

boost in positive behaviours through connection to purpose

Can’t Stop, Won’t Stop: A Connected People Event

A new narrative focused on connection to purpose, energises, empowers and refocuses the senior team at Pfizer’s lacklustre immuno-inflammatory business, taking every team member on an exciting, high-potential journey

52% rise

in positive leadership behaviours throughout the organisation

$6.7B

value added through purpose-driven transformation

2,000+

colleagues united in a global interactive virtual event

A Wave of Change 

A health franchise within a leading BPO partnered with Open Water to align its identity and deliver exceptional results, positioning it as preferred UK healthcare provider

Exceptional Results

From consultants to trusted advisors

Self-Leadership

Confidence, collaboration, and clarity unlocked

Growth Mindset

EQ-driven change powers growth

Rare Synergy

A complete cultural shift creates optimism and a new sense of identity, belonging and purpose post-merger for a specialist biopharma

250

leaders aligned successfully post merger

Strong Sense of Belonging

from 'lone wolves' to a collaborative ethos

Unified Vision

culture transformation delivered results within weeks

Connected Leaders are Market Leaders

Driving transformation with EQ: Empowering consultants to align values, build trust, and deliver an ambitious vision.

Expert Trusted Advisors

connected leaders drive market success

From Alignment to Action

building trust, shaping culture and leading the change

No. 1 Market Lead

post-merger results exceed expectations after Open Water program